Charles H. Sherwood, CEO and Director at Anika Therapeutics, Inc. (ANIK), sold 12,340 shares at $60.00 ($742K) on 2017-10-12, disclosed to the SEC on 2017-10-16.
Open-market sale of $742k ANIK by CEO and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.00 | 1,908 | $114K | 15.4% |
| 2 | $60.11 | 5,216 | $314K | 42.3% |
| 3 | $60.11 | 5,216 | $314K | 42.3% |
| Total | $60.09 avg | 12,340 | $742K | 100% |
| Filing → |
| ANIK | SELL | 2017-10-18 | $395K | — | Filing → |
| ANIK | SELL | 2017-07-31 | $6.5M | — | Filing → |
| ANIK | SELL | 2017-07-06 | $1.1M | — | Filing → |